GDF2026 - Overview of the FDA Product-Specific Guidance (PSG) Program
U.S. Food and Drug Administration (FDA) · July 30, 2026
Agency official from the U.S. Food and Drug Administration presented an overview of the Product Specific Guidance (PSG) program, its publication schedule, GDUFA‑3 commitments and how industry can engage via public requests, comments, and PSG teleconferences.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.